Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001399529-21-000204
Filing Date
2021-12-29
Accepted
2021-12-29 16:21:51
Documents
1
Period of Report
2021-12-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164081289891815.html 4  
1 FORM 4 wf-form4_164081289891815.xml 4 15431
  Complete submission text file 0001399529-21-000204.txt   16748
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019
Business Address
Smith Cynthia (Reporting) CIK: 0001609480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 211529113